The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hesterberg Lyndal K. since 2018.
The trader's CIK number is 1689836.
At the time of the last reporting, Hesterberg Lyndal K. was the Sr VP, Research & Development of Oncocyte Corp. (stock ticker symbol OCX).
Also see all insider trading activities at Oncocyte Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | OCX | 874 | $0 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-07-26 | OCX | Buy | 874 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hesterberg Lyndal K. (Sr VP, Research & Development of Oncocyte Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.